Lupin partners with Mark Cuban and COPD Foundation to expand access to COPD medication in the US
Chronic obstructive pulmonary disease affects over 15 million adults in the US and ranks as the fourth leading cause of death
Alex Oshmyansky Spiriva Handihaler Spiro Gavaris Jean Wright Mark Cuban Cost Plus Drug Company Boehringer Ingelheim Pharmaceuticals
Source: businesstoday.in